Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 ; volume:11 ; number:1 ; day:4 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Nature Communications ; 11, Heft 1 (4.11.2020), 1-11, 12.2020

Creator: Custódio, Tânia F.
Das, Hrishikesh
Sheward, Daniel J.
Hanke, Leo
Pazicky, Samuel
Pieprzyk, Joanna
Sorgenfrei, Michèle
Schroer, Martin A.
Gruzinov, Andrey Yu
Jeffries, Cy M.
Graewert, Melissa A.
Svergun, Dmitri I.
Dobrev, Nikolay
Remans, Kim
Seeger, Markus A.
McInerney, Gerald M.
Murrell, Ben
Hällberg, B. Martin
Löw, Christian

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-020-19204-y

URN: urn:nbn:de:101:1-2020121314535292864331

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Custódio, Tânia F.
Das, Hrishikesh
Sheward, Daniel J.
Hanke, Leo
Pazicky, Samuel
Pieprzyk, Joanna
Sorgenfrei, Michèle
Schroer, Martin A.
Gruzinov, Andrey Yu
Jeffries, Cy M.
Graewert, Melissa A.
Svergun, Dmitri I.
Dobrev, Nikolay
Remans, Kim
Seeger, Markus A.
McInerney, Gerald M.
Murrell, Ben
Hällberg, B. Martin
Löw, Christian
SpringerLink (Online service)

Other Objects (12)

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Hochschulschrift

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Hochschulschrift

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Hochschulschrift

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Therapeutische Nanobodies gegen SARS-CoV-2

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2

Synthetic Sphingolipid analogues biophysical properties and subcellular localization

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies

Online biophysical predictions for SARS-CoV-2 proteins

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The Therapeutic Potential of Nanobodies

Nanobodies – effektive Immunwaffen gegen Krebs

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Related objects

Reset password